41
Wolf HPO, Brenner KV.
The Effect of Etomoxir on Glucose Turnover and Recycling with (1-14C), (3-3H) – Glucose Tracer in Pigs. Horm. Metabol. Res. 20 (1988) 204-207.

42
Vidal H, Comte B, Beylot M, Riou J-P.
Inhibition of Glucose Oxidation by Vasoactive Intestinal Peptide in Isolated Rat Enterocytes. J. Biol. Chem. 263 (1988) 9206-9211.

43
Baht HS, Saggerson ED.
Effect of noradrenaline on triglycerol synthesis in rat brown adipocytes. Biochem. J. 258 (1989) 369-373.

44
Collier GR, Traianedes K, O`Dea K.
Effect of Etomoxir on In Vivo Glucose Metabolism in High Fat Fed Streptozotocin Treated Rats. Diabetologia 32 (1989) No. 7, 477A.

45
Crilley, MML, Edmunds AJF, Eistetter K, Golding BT.
Synthesis of Enantiomers of 2-(6-(4-chlorophenoxy)hexyl)-oxirane-2-carboxylic acid. Tetrahydron Lett. 30 (1989) 885-888.

46
Fulcher GR, Alberti KGMM.
The role of inhibitors of lipolysis and lipid oxidation in the treatment of non-insulin-dependent diabetes. in Alberti KGMM, Mazze R: Frontiers of diabetes research: current trends in non-insulin-dependent diabetes mellitus, Elsevier Science Publishers B.

47
Lopaschuk GD, Spafford M.
Response of Isolated Working Hearts to Fatty Acids and Carnitine Palmitoyltransferase I Inhibition During Reduction of Coronary Flow in Acutely and Chronically Diabetic Rats. Circ. Res. 65 (1989) 378-387.

48
Lopaschuk GD, McNeill GF, McVeigh JJ.
Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir. Mol. Cell. Biochem. 88 (1989) 175-179. 49 McGarry JD, Woeltje KF, Kuwajima M, Foster DW. Regulation of ketogenesis and the renaisa

50
Rösen P, Schmitz FJ, Reinauer H.
Influence of the CPT-inhibitor Etomoxir on myocardial function and metabolism in vivo. Z. Kardol. 78 (1989) Suppl 1, P83.

51
Selby PL, Sherratt HSA.
Substituted 2-oxiranecarboxylic acids: a new group of candidate hypoglycaemic drugs. Trends Pharmacol. Sci. 10 (1989) 495-500.